Skip to main content
Watch Insiders
Market intelligence
PBLSSector not reported

Parabilis Medicines, Inc. insider activity

In the last 90 days, 6 corporate insiders purchased $2,119,598,529 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$2,119,598,529
Corporate buyers
6
Latest transaction
Jun 15, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 15, 2026Alan SebulskyDirectorOpen Market Purchase17,500$27.06$473,529
Jun 11, 2026Ra Capital Healthcare Fund LpCorporate insiderOpen Market Purchase21,188,750$20.00$423,775,000
Jun 11, 2026Ra Capital Management L.p.Director / 10% OwnerOpen Market Purchase21,188,750$20.00$423,775,000
Subscribe to see more data